The Role of VEGF and CTGF in Diabetic Retinopathy
Author Information
Author(s): Kuiper Esther J., Van Nieuwenhoven Frans A., de Smet Marc D., van Meurs Jan C., Tanck Michael W., Oliver Noelynn, Klaassen Ingeborg, Van Noorden Cornelis J. F., Goldschmeding Roel, Schlingemann Reinier O.
Primary Institution: Academic Medical Center, University of Amsterdam
Hypothesis
The balance between levels of pro-angiogenic VEGF and pro-fibrotic CTGF regulates angiogenesis and the resulting fibrosis in proliferative diabetic retinopathy.
Conclusion
CTGF is primarily a pro-fibrotic factor in the eye, and a shift in the balance between CTGF and VEGF is associated with the switch from angiogenesis to fibrosis in proliferative retinopathy.
Supporting Evidence
- CTGF levels were significantly associated with the degree of fibrosis in PDR patients.
- VEGF levels were associated only with neovascularization.
- The ratio of CTGF to VEGF was the strongest predictor of fibrosis.
- Patients with PDR showed increased fibrosis after anti-VEGF treatment.
Takeaway
This study shows that two proteins, VEGF and CTGF, work together in the eye, where too much CTGF can lead to scarring and blindness instead of healing.
Methodology
Vitreous samples were collected from patients and levels of VEGF and CTGF were measured using ELISA, with statistical analysis performed to assess correlations.
Potential Biases
Potential bias due to the retrospective nature of the study and the reliance on clinical records.
Limitations
The study is limited by its retrospective design and the small number of patients analyzed for specific treatments.
Participant Demographics
Patients included 32 with proliferative diabetic retinopathy, 13 with macular hole, and 23 with macular pucker, with a mean age of 54.2 for PDR patients.
Statistical Information
P-Value
p<0.001
Confidence Interval
[20.5–27.7]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website